J. Fay

发表

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

R. Stallings, A. Davidoff, K. Bryan, 2012, British Journal of Cancer.

High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer

J. Prehn, E. Kay, J. Fay, 2015, Radiation oncology.

Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH)

B. Hennessy, J. Crown, S. Furney, 2018, PloS one.

Abstract 2290: MiR-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-beta signalling pathway

R. Stallings, K. Bryan, D. Murphy, 2012 .

A 57-Nucleotide Upstream Early Polyadenylation Element in Human Papillomavirus Type 16 Interacts with hFip1, CstF-64, hnRNP C1/C2, and Polypyrimidine Tract Binding Protein

Xiaomin Zhao, D. Öberg, S. Schwartz, 2005, Journal of Virology.

Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panel.

R. Cummins, J. Naidoo, S. Madden, 2022, Lung cancer.

Development of a Novel Weighted Ranking Method for Immunohistochemical Quantification of a Heterogeneously Expressed Protein in Gastro-Esophageal Cancers

K. Jirström, A. Hopkins, Cathy E. Richards, 2021, Cancers.

Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer

J. Prehn, C. Concannon, E. Kay, 2016, Journal of Translational Medicine.

HPV‐16 E2 contributes to induction of HPV‐16 late gene expression by inhibiting early polyadenylation

D. Pim, L. Banks, C. Johansson, 2012, The EMBO journal.

Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation

M. Lamfers, A. Idbaih, L. Hudson, 2021, Cell Death & Disease.

Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer

P. Morris, B. Hennessy, A. Farrelly, 2021, Journal of Translational Medicine.

Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies

A. Hill, B. Hennessy, J. Crown, 2017, Breast Cancer Research.

Human Epidermal Growth Factor Receptor-3 Expression Is Regulated at Transcriptional Level in Breast Cancer Settings by Junctional Adhesion Molecule-A via a Pathway Involving Beta-Catenin and FOXA1

K. Jirström, K. Brennan, L. Hudson, 2021, Cancers.

The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer

G. Cavalleri, B. Hennessy, J. Crown, 2016, Oncotarget.

MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway.

R. Stallings, K. Bryan, D. Murphy, 2012, Carcinogenesis.

Modulation of Neuroblastoma Disease Pathogenesis By An Extensive Network of Epigenetically Regulated MicroRNAs

R. Stallings, F. Speleman, J. Vandesompele, 2012, Oncogene.

Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach

H. Schulze‐Bergkamen, J. Prehn, E. Kay, 2016, Cell Death and Disease.

The organization of the gamma-glutamyl transferase genes and other low copy repeats in human chromosome 22q11.

I. Dunham, A. Mungall, J. Collins, 1997, Genome research.

Tumour Genome Characterization of a Rare Case of Pulmonary Enteric Adenocarcinoma and Prior Colon Adenocarcinoma

P. Morris, B. Hennessy, S. Furney, 2021, Journal of personalized medicine.

Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

B. O'neill, P. Morris, B. Hennessy, 2020, Cancers.

BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer

B. Hennessy, J. Prehn, E. Kay, 2015, Journal of Molecular Medicine.

Development and progress of Ireland's biobank network: Ethical, legal, and social implications (ELSI), standardized documentation, sample and data release, and international perspective.

E. Gaffney, S. Glynn, F. Giles, 2013, Biopreservation and biobanking.

Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer

P. Morris, A. Hill, B. Hennessy, 2018, Therapeutic advances in medical oncology.

Caspase-11 regulates the tumour suppressor function of STAT1 in a murine model of colitis-associated carcinogenesis

E. Kay, C. Nulty, K. Mills, 2018, Oncogene.

Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples

P. Morris, K. O'Byrne, B. Hennessy, 2020, Journal of Translational Medicine.

Adenovirus E4orf4 induces HPV-16 late L1 mRNA production.

G. Akusjärvi, S. Schwartz, H. Lambkin, 2009, Virology.

Adenovirus E4orf4 induces HPV-16 late L1 mRNA production.

G. Akusjärvi, S. Schwartz, H. Lambkin, 2009, Virology.

Formulation of an immunogenic human cytomegalovirus vaccine: responses in mice.

W. Britt, C. Kensil, J. Fay, 1995, The Journal of infectious diseases.

Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus

W. Britt, M. Mach, J. Fay, 1991, Journal of virology.

A Downstream Polyadenylation Element in Human Papillomavirus Type 16 L2 Encodes Multiple GGG Motifs and Interacts with hnRNP H

S. Schwartz, H. Lambkin, J. Fay, 2005, Journal of Virology.

Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers.

Xiaomin Zhao, S. Schwartz, H. Lambkin, 2007, Virology.

Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential

D. Laukens, K. Sheahan, A. O'Grady, 2015, Clinical and experimental immunology.

Can a biobank network and supporting infrastructure enhance Ireland's ability to attract pharmaceutical research and development and clinical trial opportunities? A pilot survey

E. Gaffney, Ronan Ward, S. Glynn, 2016 .

The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer

M. Rehm, J. Prehn, E. Kay, 2018, Cell Death & Disease.

Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples

P. Morris, K. O'Byrne, B. Hennessy, 2020, Journal of Translational Medicine.

Increased expression of cellular RNA‐binding proteins in HPV‐induced neoplasia and cervical cancer

S. Schwartz, P. Kelehan, H. Lambkin, 2009, Journal of medical virology.

Calnexin, an ER-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer

J. Prehn, C. Concannon, E. Kay, 2016, Journal of Translational Medicine.

Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression

S. Sukumar, K. Brennan, L. Hudson, 2022, Cancers.

The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer

B. Hennessy, E. Kay, W. Gallagher, 2021, Breast Cancer Research and Treatment.

Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism.

C. Johansson, S. Schwartz, R. Chang, 2011, The Journal of general virology.

Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)

K. O'Byrne, L. Hudson, B. Hennessy, 2015, International journal of molecular sciences.

RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

B. Hennessy, K. Pritzker, J. Crown, 2016, Journal of the National Cancer Institute.

Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)

K. O'Byrne, L. Hudson, B. Hennessy, 2023, International journal of molecular sciences.

Impact of somatic PIK3CA and ERBB family mutations on pathological complete reponse (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.

B. Hennessy, J. Crown, E. Kay, 2016 .

Comparison of the prognostic performance between OncoMasTR and OncotypeDX multigene signatures in hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.

J. Crown, A. O'Grady, C. Kelly, 2018 .

Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors.

J. Crown, A. O'Grady, A. Bracken, 2021, European journal of cancer.